# Combination Of PAXIL Tablet And Benzodiazepines

> **NCT00259883** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 150 (actual)

## Conditions studied

- Mental Disorders

## Interventions

- **DRUG:** paroxetine

## Key facts

- **NCT ID:** NCT00259883
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259883, "Combination Of PAXIL Tablet And Benzodiazepines". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00259883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*